CD8+ T cells can inhibit tumour growth and progression in CRC, and strategies for increasing CD8+ T cell infiltration have slowed tumour growth and extended survival in animal models.17 There was no difference between the sexes in CD8+ T cell levels within the peritumoural (peritoneal) compartment. This evidence concerns the gene CD8A and colorectal carcinoma.